Skip to content

KWIEK. A randomised controlled trial investigating the effectiveness of an integrated multidimensional lifestyle program on disability, self-management and quality of life in frail older adults aged 65 and over living independently in the rural community of Wijk bij Duurstede and Maarn-Maarsbergen (community of Utrechtse Heuvelrug).

KWIEK. A randomised controlled trial investigating the effectiveness of an integrated multidimensional lifestyle program on disability, self-management and quality of life in frail older adults aged 65 and over living independently in the rural community of Wijk bij Duurstede and Maarn-Maarsbergen (community of Utrechtse Heuvelrug). - KWIEK, a lifestyle program, testing its effectiveness in frail elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39577
Enrollment
400
Registered
2012-08-30
Start date
2012-08-31
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bewegen, eenzaamheid, voedingspatroon en polyfarmacie (fysiotherapie en psycho-sociaal) selfmanagement

Interventions

KWIEK is a group-based program. Mean group size is 8 - 10 older adults. The KWIEK-program consist of four components: monitoring medication by means of Prescribing Optimization Method, a physical tr

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Groninger Frailty Index (GFI) score of 1 or higher Living on their own/community of Wijk bij Duurstede Age 65 and over;This study focuses on community-dwelling older people (>= 65 years) in different stages of our frailty concept. 400 older adults are included, of whom 200 will receive te intervention, 200 will be included in the controll condition. ;The GFI is a screener for frailty. Frailty is indicated at a score from 3 or higher. In this study older adults with different stages of frailty are included, which enables us to investigate the effectiveness of the intervention in these differents stages of frailty.

Exclusion criteria

Exclusion criteria: Cognitive impairment (MMSE

Design outcomes

Primary

MeasureTime frame
Primary outcome of the study is disability (measured by Groningen Activity Restriction Scale (GARS).

Secondary

MeasureTime frame
Quality of Life measured by means of The Short Form-12 (SF-12) and self-management in daily living by means of the KATZ-ADL (6) and the Self Management Ability Scale (SMAS-30).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)